682P Results from ADVANCE: A Phase I/II Open-Label Non-Randomised Safety and Efficacy Study of the Viral Vectored ChAdOx1-MVA 5T4 (VTP-800) Vaccine in Combination with PD-1 Checkpoint Blockade in Metastatic Prostate Cancer
ANNALS OF ONCOLOGY（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined